soul trial oral semaglutide cardiovascular outcomes 2024 2025 found to lower risk of heart failure events in people with type 2 diabetes SOUL (Semaglutide cardiOvascular oUtcomes triaL)
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3































